International Chemical Entity Japan Co., Ltd.September 5, 2025

FDA 483 - International Chemical Entity Japan Co., Ltd. - September 05, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore International Chemical Entity Japan Co., Ltd.

Record Details

An FDA inspection of International Chemical Entity Japan Co., Ltd., an API manufacturer in Iwaki, Fukushima, Japan, revealed two significant observations. The firm failed to establish scientifically sound procedures for identifying microorganisms in environmental and water samples and did not use validated, stability-indicating test procedures, specifically omitting forced degradation studies. These deficiencies undermine product quality assurance and patient safety.

Company: International Chemical Entity Japan Co., Ltd.
Inspection Date: September 5, 2025
Product Type: Drugs
Office: Office of Inspections and Investigations
People: Geoffrey Kiillii
Geoffrey K. Kilili (investigator)

Open in Dashboard

ID · b060dc73-a214-47b9-8f55-70ec178290f0